FOXO4-DRI is a specialized research peptide provided by Peptides Lab UK in a high-purity lyophilised format, ideal for detailed in vitro studies and pre-clinical molecular research. This peptide is a designed FOXO4-p53 interfering peptide, studied extensively for its role in modulating cellular senescence and apoptotic pathways by disrupting the interaction between FOXO4 and p53 proteins. Researchers utilize FOXO4-DRI to explore mechanisms involved in aging, cellular stress responses, and senescence-associated secretory phenotypes (SASP).

Each batch from Peptides Lab UK undergoes rigorous HPLC verification to ensure purity levels exceeding 99%, guaranteeing reliable results in biochemical assays, molecular pathway analyses, and cell signaling investigations.

Product Specifications
– Purity: >99% (HPLC Verified)
– Form: Lyophilised powder
– Storage: Store dry at -20°C; protect from light
– Solubility: Compatible with bacteriostatic water, sterile water, or suitable laboratory solvents

Research Applications
– In vitro studies on cellular senescence and apoptosis regulation
– Analysis of protein-protein interactions within senescence pathways
– Pre-clinical research targeting age-related diseases and cellular longevity
– Structural and functional studies related to signal transduction

Important Notice
Distributed by Peptides Lab UK exclusively for laboratory research use only. This compound is not intended for human consumption, medical, or veterinary applications. Handling should be conducted by qualified laboratory personnel under controlled conditions.

>99% Purity Verified | For Laboratory Research Only | Not for Human or Veterinary Use.